![]() |
产地 | 中国 |
品牌 | 爱必信(absin) |
货号 | abs812157 |
用途 | 见爱必信官网 |
英文名称 | 见爱必信官网 |
包装规格 | 10mg,50mg |
纯度 | >98%% |
CAS编号 | 658084-64-1 |
别名 | 达珀利奈;Daporinad; APO866; FK-866; FK 866; APO 866; APO-866 |
是否进口 | 否 |
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:FK866 产品别名:见爱必信官网 英文别名:FK866 靶点:NAMPT CAS:658084-64-1 纯度:>98% 外观:见爱必信官网 保存方法:Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. 描述: FK866 (APO866, Daporinad)有效抑制烟酰胺磷酸核糖转移酶(NMPRTase),无细胞试验中IC50为0.09 nM。 溶解性:Ethanol:78 mg/mL (199.22 mM) 体外研究:
APO866 at low concentrations ranging from 0.09-27 nM induces dose-dependent cytotoxicity in 41 hematologic malignant cells including acute myeloid leukemia , acute lymphoblastic leukemia , mantle cell lymphoma , chronic lymphocytic leukemia , and T-cell lymphoma. APO866 at low concentrations ranging from 0-10 nM induces cell death, this effect is independent of caspase activation but is associated with depolarization of mitochondrial membrane. APO866 at concentrations ranging from 0-10 nM dose-dependently induces depletion of intracellular NAD and ATP contents and cell death in various hematologic cancer cells. APO866 at concentration of 10 nM inhibits PBEF-induced secretion of MMP-3, CCL2, and CXCL8 in HFFF2 cells. 体内研究:APO866 administered intraperitoneally at dose of 20 mg/kg twice a day for 4 days, repeat weekly over 3 weeks, prevents and abrogats tumor growth in C.B.-17 SCID mice xenograft models of human AML, lymphoblastic lymphoma, and leukemia. APO866 at dose of 0.12 mg/kg/hour prevents joint destruction and leukocyte infiltration through inhibition of PBEF in mice with CIA.
产品信息订购:
|